7-43444677-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000395891.7(HECW1):āc.1505A>Gā(p.Glu502Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,605,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000395891.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HECW1 | NM_015052.5 | c.1505A>G | p.Glu502Gly | missense_variant | 11/30 | ENST00000395891.7 | NP_055867.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HECW1 | ENST00000395891.7 | c.1505A>G | p.Glu502Gly | missense_variant | 11/30 | 1 | NM_015052.5 | ENSP00000379228 | P2 | |
HECW1 | ENST00000453890.5 | c.1505A>G | p.Glu502Gly | missense_variant | 10/28 | 2 | ENSP00000407774 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000174 AC: 4AN: 230034Hom.: 0 AF XY: 0.0000240 AC XY: 3AN XY: 125160
GnomAD4 exome AF: 0.00000757 AC: 11AN: 1453698Hom.: 0 Cov.: 34 AF XY: 0.00000692 AC XY: 5AN XY: 722506
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.1505A>G (p.E502G) alteration is located in exon 11 (coding exon 9) of the HECW1 gene. This alteration results from a A to G substitution at nucleotide position 1505, causing the glutamic acid (E) at amino acid position 502 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at